XNAS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
DexCom (DXCM) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refer…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/12/2026 | Heller Bridgette P | — | SELL | -1,012 | $60 | $60,730 |
| 5/8/2026 | ALTMAN STEVEN R | — | GIFT | 5,037 | — | — |
| 5/8/2026 | ALTMAN STEVEN R | — | GIFT | -5,037 | — | — |
| 5/8/2026 | FOLETTA MARK G | — | GIFT | 5,731 | — | — |
| 5/8/2026 | FOLETTA MARK G | — | GIFT | -5,731 | — | — |
| 5/8/2026 | Collins Richard Alexander | — | GIFT | 5,074 | — | — |
| 5/8/2026 | Collins Richard Alexander | — | GIFT | -5,074 | — | — |
| 5/8/2026 | AUGUSTINOS NICHOLAS | — | GIFT | 5,046 | — | — |
| 5/8/2026 | AUGUSTINOS NICHOLAS | — | GIFT | -5,046 | — | — |
| 4/15/2026 | Brown Michael Jon | EVP, Chief Legal Officer | SELL | -1,700 | $63 | $107,168 |
| 3/16/2026 | Brown Michael Jon | EVP, Chief Legal Officer | SELL | -1,700 | $65 | $110,245 |
| 3/8/2026 | SAYER KEVIN R | Executive Chair | GRANT | 32,749 | — | — |
| 3/8/2026 | SAYER KEVIN R | Executive Chair | TAX_WITHHOLD | -32,498 | $68 | $2,213,114 |
| 3/8/2026 | Sylvain Jereme M | EVP, Chief Financal Officer | GRANT | 48,774 | — | — |
| 3/8/2026 | Sylvain Jereme M | EVP, Chief Financal Officer | TAX_WITHHOLD | -18,950 | $68 | $1,290,495 |
| 3/8/2026 | Brown Michael Jon | EVP, Chief Legal Officer | GRANT | 39,019 | — | — |
| 3/8/2026 | Brown Michael Jon | EVP, Chief Legal Officer | TAX_WITHHOLD | -23,325 | $68 | $1,588,433 |
| 3/8/2026 | Stern Sadie | EVP, Chief HR Officer | GRANT | 39,019 | — | — |
| 3/8/2026 | Stern Sadie | EVP, Chief HR Officer | TAX_WITHHOLD | -17,199 | $68 | $1,171,252 |
| 3/8/2026 | Leach Jacob Steven | President, CEO, and Director | GRANT | 104,516 | — | — |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 99,324,365 | $3,977,499,286 | — | 8/13/2024 |
| Vanguard Group | 49,074,378 | $3,257,066,468 | — | 1/29/2026 |
| State Street | 44,718,554 | $1,225,353,183 | — | 2/13/2026 |
| JP Morgan Chase | 25,882,101 | $442,059,883 | — | 2/11/2026 |
| DE Shaw | 4,145,568 | $275,141,348 | — | 2/17/2026 |
| AQR Capital | 3,102,789 | $205,932,104 | — | 2/17/2026 |
| Millennium Management | 1,923,277 | $127,647,894 | — | 2/17/2026 |
| Citadel Advisors | 1,733,300 | $115,039,121 | — | 2/17/2026 |
| Fidelity (FMR) | 15,060,642 | $98,845,024 | — | 2/17/2026 |
| Point72 | 1,451,107 | $96,309,972 | — | 2/17/2026 |
| Two Sigma | 13,082,913 | $82,906,936 | — | 2/17/2026 |
| Bridgewater Associates | 149,264 | $9,906,652 | — | 2/13/2026 |